Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05456321
Other study ID # PSYCH-2022-30910
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 10, 2022
Est. completion date May 31, 2027

Study information

Verified date November 2023
Source University of Minnesota
Contact Jeffrey Wozniak, PhD
Phone 1-612-598-0041
Email jwozniak@umn.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a randomized placebo-controlled trial of cognitive training with transcranial direct current stimulation (tDCS) for children and adolescents (ages 8 - 17 years) with prenatal alcohol exposure (PAE).


Description:

Prenatal alcohol exposure (PAE) has profound detrimental effects on brain development and, as a result, has permanent consequences for cognition, learning, and behavior. Individuals with Fetal Alcohol Spectrum Disorders (FASD) commonly have a range of neurocognitive impairments that directly lead to practical problems with learning, attention, working memory, task planning/execution, and decision making, among other areas of functioning. Despite the profound public health burden posed by FASD, there have been very few treatment studies in this population. This study will examine the effects of a cognitive remediation training augmented with transcranial direct current stimulation (tDCS) in children and adolescents with PAE. The study involves a baseline visit with cognitive testing, 5 sessions of tDCS (including the baseline visit) with active and sham arms, a 6th visit for cognitive testing.


Recruitment information / eligibility

Status Recruiting
Enrollment 70
Est. completion date May 31, 2027
Est. primary completion date May 31, 2027
Accepts healthy volunteers No
Gender All
Age group 8 Years to 17 Years
Eligibility Inclusion Criteria: - Documented heavy prenatal alcohol exposure (self-report, social service records, or adoption records) and meeting criteria for an associated FASD diagnosis (FAS, partial FAS, or ARND). - An available parent or legal guardian capable of giving informed consent Exclusion Criteria: - Substance abuse in the participant - Neurological condition or other developmental disorder - Serious psychiatric disorder known to affect brain functioning and cognitive performance Birthweight < 1500 grams - MRI contraindication - tDCS contraindication

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Active tDCS
Active Transcranial Direct Current Stimulation (tDCS)
Behavioral:
Cognitive Training
Computerized Cognitive Training
Device:
Sham tDCS
Sham Transcranial Direct Current Stimulation (tDCS)

Locations

Country Name City State
United States University of Minnesota Minneapolis Minnesota

Sponsors (1)

Lead Sponsor Collaborator
University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Continuous Performance Test performance Change in Continuous Performance Test performance After each study visit (approx. bi-weekly) for the duration of the study (10 visits, approx. 5 weeks)
Primary Change in Delis-Kaplan Executive Function System -Trail Making performance Change in Delis-Kaplan Executive Function System - Trail Making performance Visit 1 and Visit 5 (approx. 3 weeks apart)
Primary Change in Delis-Kaplan Executive Function System Color Word Interference performance Change in Delis-Kaplan Executive Function System - Color Word Interference performance Visit 1 and Visit 5 (approx. 3 weeks apart)
Primary Change in Wechsler Digit Span performance Change in Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Digit Span performance Visit 1 and Visit 5 (approx. 3 weeks apart)
Primary Change in Wechsler Picture Span performance Change in Wechsler Intelligence Scale for Children or Wechsler Adult Intelligence Scale Picture Span performance Visit 1 and Visit 5 (approx. 3 weeks apart)
Secondary Change in Oral Word Reading Fluency performance Change in Oral Word Reading Fluency performance Visit 1 and Visit 5 (approx. 3 weeks apart)
Secondary Change in Math Fluency performance Change in Mathematics Fluency performance Visit 1 and Visit 5 (approx. 3 weeks apart)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Completed NCT01961050 - Preventing FAS/ARND in Russian Children N/A
Recruiting NCT05108974 - Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study Phase 2
Completed NCT02457676 - Improving Self Regulation in Children With Fetal Alcohol Syndrome Spectrum Disorders: A Neuroplastic Intervention N/A
Recruiting NCT06005181 - The Synchrony Study: Examining Music Training for Children With FASD N/A
Completed NCT04571463 - Ethyl Glucuronide in Urine Samples of Pregnant Women Within the HUS ja PHHYKY Area
Completed NCT03361293 - Cognitive Training and tDCS for Children With FASD N/A
Recruiting NCT05534568 - The Oklahoma Parent-Child Assistance Program N/A
Completed NCT01911299 - Choline Supplementation in Children With Fetal Alcohol Spectrum Disorders Phase 2
Recruiting NCT04332172 - Scaling Up: A Multi-Site Trial of e-SBI for Alcohol Use in Pregnancy N/A
Recruiting NCT05960461 - Families Moving Forward (FMF) Connect Pro for Mental Health Providers N/A
Completed NCT05604014 - Feasibility Study of the My Health Coach App for Adults With FASD N/A
Terminated NCT03852550 - READYorNot[TM] Brain-Based Disabilities Trial N/A
Completed NCT02735473 - Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Phase 2
Completed NCT03782935 - Nutritional Risk Factors for FASD in Ukraine N/A
Not yet recruiting NCT04918043 - Alcohol Use During Pregnancy in Finland According to Meconium Samples
Completed NCT04072809 - Dissecting the Genetics of Fetal Alcohol Spectrum Disorders
Completed NCT01149538 - Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure Phase 1/Phase 2
Completed NCT05028517 - Efficacy Trial of the FMF Connect Mobile Health Intervention N/A
Completed NCT04194489 - Trial of the Families Moving Forward (FMF) Connect Mobile Health Intervention N/A